Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours
article
OA: bronze
CC0
⤵ 69 in-corpus citations
AI-generated summary
Serum IL-6 was higher in ovarian cancer, while serum TNF-alpha differed between benign and endometriomas, and cyst fluid IL-8 was higher in endometriomas than benign tumors.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Altered expression of cytokines has been suggested as a specific event for the maintenance and progression of endometriomas. Few data exist on cytokine expression in endometriomas compared with benign and malignant ovarian tumours. Hence, serum and cyst fluid levels of interleukin (IL)-6, IL-8 and tumour necrosis factor-alpha (TNF-alpha) were evaluated in women with endometriomas and compared with those in women with benign or malignant ovarian tumours. METHODS: Investigations included immunoradiometric determination of serum and cyst fluid concentrations of IL-6, IL-8 and TNF-alpha in 34 women with endometriomas, 30 women with benign and 13 women with malignant cystic ovarian tumours. RESULTS: Serum IL-6 levels were higher in ovarian cancer than in endometriomas (P<0.01) or benign tumours (P<0.01). Serum TNF-alpha levels differed between benign tumours and endometriomas (P<0.01), but not between endometriomas and malignant tumours. Cyst fluid levels of IL-8 were higher in endometriomas than in benign tumours (P<0.001) and lower than in malignant tumours (P=0.03). Cyst fluid levels of TNF-alpha differed between malignant tumours and endometriomas (P<0.01) and benign tumours (P<0.01), but not between endometriomas and benign tumours. In the endometriomas group, a positive correlation was found between serum and cyst fluid levels of IL-6 (P=0.003, rho=0.633), and between serum levels of IL-6 and IL-8 (P=0.03, rho=0.415). CONCLUSIONS: Endometriomas were associated with serum TNF-alpha levels similar to those found in women with ovarian cancer, while serum IL-6 levels and cyst fluid IL-8 levels were intermediate between those observed in benign and malignant ovarian tumours.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (42)
- Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis via openalex
- Association of interleukin‐6 and estradiol with hepatocyte growth factor in peritoneal fluid of women with endometriosis via openalex
- Cytokine profiles in autologous peritoneal fluid and peripheral blood of women with deep and superficial endometriosis via openalex
- Cytokines in the peritoneal fluid of patients with endometriosis via openalex
- Deficient cellular immunity in endometriosis via openalex
- Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. via openalex
- Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro via openalex
- Effect of tumor necrosis factor-α on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system via openalex
- Endocrinology and paracrinology via openalex
- High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata via openalex
- Immunobiology of endometriosis via openalex
- Increased activation of pelvic macrophages in infertile women with mild endometriosis via openalex
- Interferon‐Gamma (IFN‐γ) and Interleukin‐6 (IL‐6) in Peritoneal Fluid and Macrophage‐Conditioned Media of Women With Endometriosis via openalex
- Interleukin-8 Induces Proliferation of Endometrial Stromal Cells: a Potential Autocrine Growth Factor1 via openalex
- Interleukin-8 in the Human Endometrium<sup>1</sup> via openalex
- Local Cytokines in Endometrial Tissue: The Role of Interleukin‐8 in the Pathogenesis of Endometriosis via openalex
- Pathogenetic Significance of Increased Levels of Interleukin-8 in the Peritoneal Fluid of Patients with Endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: relationship to stage of disease via openalex
- The pattern of cytokine mRNA expression in ovarian endometriomata via openalex
- Tumour necrosis factor α concentrations in the peritoneal fluid of infertile women with minimal or mild endometriosis are lower in patients with red lesions only than in patients without red lesions via openalex
- Uterus and endometrium: Inhibition of human endometrial stromal cell proliferation by interleukin 6 via openalex
- W2108087308 via openalex
- W2049625691 via openalex
- W2135718978 via openalex
- W2140200809 via openalex
- W2146292641 via openalex
- W2147624141 via openalex
- W2152026308 via openalex
- W2039144212 via openalex
- W2163878996 via openalex
- W2023111652 via openalex
- W2238870413 via openalex
- W2020669458 via openalex
- W2338288098 via openalex
- W2014444795 via openalex
- W1993422257 via openalex
- W2418200982 via openalex
- W2418357148 via openalex
- W2426778538 via openalex
- W4234516729 via openalex
- W4250972286 via openalex
Cited by (50)
- Mechanisms of Endometrioma-Mediated Ovarian Damage: Myths and Facts 2025
- The Multifactorial Pathogenesis of Endometriosis: A Narrative Review Integrating Hormonal, Immune, and Microbiome Aspects 2025
- Neutrophil to lymphocytes ratio in deep infiltrating endometriosis as a new toll for clinical management 2024
- Serum Levels of Interleukins in Endometriosis Patients: A Systematic Review and Meta-analysis 2024
- The Role of the Immune System in the Development of Endometriosis 2022
- Endometriosis Research: From Bench to Bedside 2022
- The Role of the Microenvironment in Endometriosis: Parallels and Distinctions to Cancer 2022
- Endometriosis: not just a benign disease 2022
- The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions 2021
- Endometriosis: New Perspective for the Diagnosis of Certain Cytokines in Women and Adolescent Girls, as Well as the Progression of Disease Outgrowth: A Systematic Review 2021
- Factores inmunogen�ticos asociados al desarrollo de endometriosis 2021
- Molecular biomarkers of endometriosis 2021
- Management of Ovarian Endometrioma in Asymptomatic Reproductive Age Women 2021
- Preoperative Neutrophil-to-Lymphocyte Ratio Level is a Predictor of Postoperative Fertility in Infertile Patients with Ovarian Endometrioma 2021
- Hemoglobin-induced continuous activation of macrophages in endometriotic cysts: a potential mechanism of endometriosis development and carcinogenesis 2021
- Immunologic factors involved in the malignant transformation of endometriosis to endometriosis-associated ovarian carcinoma 2021
- Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives 2020
- Endometriosis and Cancer: Prevention and Diagnosis 2020
- Management of endometriosis-related infertility: Considerations and treatment options 2020
- Peroxisome proliferator-activated receptor-γ coactivator 1α-mediated pathway as a possible therapeutic target in endometriosis 2019
- Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis 2018
- Serum interleukin 6 and cancer antigen 125 in the non-invasive diagnosis of endometriosis 2018
- The gametotoxic effects of the endometrioma content: insights from a parthenogenetic human model 2018
- Traitement conservateur des endométriomes chez les patientes prises en charge en FIV 2017
- Therapeutic results of patients with endometriosis and ovarian cancer 2017
- Exacerbation of Endometriosis Due To Regulatory T-Cell Dysfunction 2017
- Role of Interleukin-6 and Its Receptor in Endometriosis 2017
- Progestin suppressed inflammation and cell viability of tumor necrosis factor‐α‐stimulated endometriotic stromal cells 2016
- Effects of Supplementation of Human Endometriotic Fluids on In Vitro Mouse Preantral Follicle Culture 2016
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Identifying biomarkers for non-invasive diagnosis of endometriosis 2016
- Intrafollicular iron and ferritin in women with ovarian endometriomas 2015
- To the question of complex treatment of endometriosis 2015
- Endometriosis and ovarian cancer: links, risks, and&nbsp;challenges faced 2015
- Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis 2015
- The diagnosis of endometriosis with the help of mass spectrometry (a review) 2015
- Copeptin is associated with the severity of endometriosis 2014
- Association of the neutrophil-to-lymphocyte ratio and CA 125 with the endometriosis score 2014
- Impact of surgical excision of lesions on pain in a rat model of endometriosis 2014
- Investigation of serum proteome alterations in human endometriosis 2014
- Biomarkers of Endometriosis 2014
- Clinical markers of endometriosis: Have we been too quick to judge? 2014
- Arterial stiffness is increased in young women with endometriosis 2014
- IVF outcome in women with accidental contamination of follicular fluid with endometrioma content 2014
- Can chemokines be used as biomarkers for endometriosis? A systematic review 2013
- Endometriosis and ovarian cancer 2013
- New horizons in the non-invasive diagnosis of endometriosis. 2013
- Evaluation of selected angiogenic and inflammatory markers in endometriosis before and after danazol treatment 2013
- A tumor necrosis factor-α inhibitor reduces the embryotoxic effects of endometriotic peritoneal fluid 2013
- Biomarkers of endometriosis 2013
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:12:50.257867+00:00
License: CC0
· commercial use OK